Published in Psychoneuroendocrinology on December 18, 2015
Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet (2003) 18.24
Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci (1998) 9.88
Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol (2001) 4.88
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci (2007) 4.46
Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA (2006) 4.39
Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med (2015) 3.44
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat (2010) 3.35
Hypocretin (orexin) cell loss in Parkinson's disease. Brain (2007) 3.00
Hot flashes: epidemiology and physiology. Ann N Y Acad Sci (1990) 2.70
The role of anxiety and hormonal changes in menopausal hot flashes. Menopause (2005) 2.70
Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med (2008) 2.64
Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA Intern Med (2014) 2.40
Orexin-A regulates body temperature in coordination with arousal status. Exp Biol Med (Maywood) (2001) 2.25
Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A (2001) 2.20
Comparison of objective and patient-reported hot flash measures in men with prostate cancer. J Support Oncol (2009) 2.20
Negative affect and vasomotor symptoms in the Study of Women's Health Across the Nation Daily Hormone Study. Menopause (2011) 2.19
Measuring hot flashes: summary of a National Institutes of Health workshop. Mayo Clin Proc (2004) 2.14
Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev (2004) 2.03
Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J Neurobiol (1998) 1.76
Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol (1998) 1.70
Daily vasomotor symptoms, sleep problems, and mood: using daily data to evaluate the domino hypothesis in middle-aged women. Menopause (2010) 1.65
A key role for orexin in panic anxiety. Nat Med (2009) 1.63
Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol (2005) 1.58
Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J Pharmacol Exp Ther (2009) 1.40
Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet (1983) 1.38
Alpha 2-adrenergic mechanism in menopausal hot flushes. Obstet Gynecol (1990) 1.37
Cardiovascular regulatory actions of the hypocretins in brain. Brain Res (1999) 1.31
Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum (1999) 1.28
Impact of stress on objectively recorded menopausal hot flushes and on flush report bias. Health Psychol (1990) 1.19
Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology (Berl) (2010) 1.14
Orexin, stress, and anxiety/panic states. Prog Brain Res (2012) 1.11
Cutaneous and hemodynamic responses during hot flashes in symptomatic postmenopausal women. Menopause (2008) 1.10
Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res (2005) 1.09
Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Res (2002) 1.07
Increased urinary cortisol levels during the menopausal transition. Menopause (2006) 1.06
Type of menopause, patterns of hormone therapy use, and hot flashes. Fertil Steril (2006) 1.04
Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis. BMC Womens Health (2008) 1.01
Anxiety during the menopausal transition: a systematic review. J Affect Disord (2011) 0.97
Premenstrual syndrome as a predictor of menopausal symptoms. Obstet Gynecol (2004) 0.97
Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries. J Epidemiol Community Health (2011) 0.95
Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. Physiol Behav (2012) 0.93
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold. BMC Neurosci (2013) 0.92
Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology (2001) 0.91
Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome. Neurology (2002) 0.89
Hypothalamic neuronal histamine regulates sympathetic nerve activity and expression of uncoupling protein 1 mRNA in brown adipose tissue in rats. Neuroscience (2004) 0.88
Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice? Springerplus (2014) 0.86
Hypothalamic-pituitary-adrenal responses to centrally administered orexin-A are suppressed in pregnant rats. J Neuroendocrinol (2003) 0.86
A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects. J Pharmacol Exp Ther (2015) 0.83
Mapping of microstimulation evoked responses and unit activity patterns in the lateral hypothalamic area recorded in awake humans. Technical note. J Neurosurg (2011) 0.82
OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES. Depress Anxiety (2015) 0.82
Plasma orexin-A levels in postmenopausal women: possible interaction with estrogen and correlation with cardiovascular risk status. BJOG (2010) 0.81
Ethanol and nicotine interaction within the posterior ventral tegmental area in male and female alcohol-preferring rats: evidence of synergy and differential gene activation in the nucleus accumbens shell. Psychopharmacology (Berl) (2014) 0.80
Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms? Climacteric (1998) 0.79
Menopausal symptoms: do life events predict severity of symptoms in peri- and post-menopause? Maturitas (2012) 0.77
The effect of propranolol and oxazepam on some vegetative menopausal symptoms. Ann Clin Res (1973) 0.76
Concordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women's Health Initiative Limited-Access Dataset. PLoS One (2015) 0.76